High accumulation of T regulatory cells prevents the activation of immune responses in aged animals

Journal of Immunology

Volumn 177, Issue 12, 2006, Pages 8348-8355

  Sharma, Sanjay ^a   Dominguez, Ana Lucia ^a   Lustgarten, Joseph ^a,b  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CD4 ANTIGEN; CD8 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; AGED; AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE DEFICIENCY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNOLOGY; VACCINATION;

EID: 33845408098     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.12.8348     Document Type: Article

References (36)

1. Provinciali, M., and A. Smorlesi. 2005. Immunoprevention and immunotherapy of cancer in aging. Cancer Immunol. Immunother. 54: 93-106.
2. Linton, P., and M. L. Thoman. 2001. T cell senescence. Front. Biosci. 6: D248-D261.
3. Lustgatten, J., A. L. Dominguez, and M. Thoman. 2004. Aged mice develop protective antitumor immune responses with appropriate costimulation. J. Immunol. 173: 4510-4515.
4. + immunoregulatory cells. J. Immunol. 167: 1137-1140.
5. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 160: 1212-1218.
6. + suppressor T cells. Immunol Rev. 182: 58-67.
7. Zou, W. 2006. Regulatory T cells, tumor immunity and immunotherapy. Nat. Rev. Immunol. 6: 295-307.
8. Battaglia, M., S. Gregori, R. Bacchetta, and M. G. Roncarolo. 2006. Tr1 cells: from discovery to their clinical application. Semin. Immunol. 18: 120-127.
9. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
10. Knutson, K. L., M. L. Disis, and L. G. Salazar. 2006. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol. Immunother. In press.
11. Sakaguchi, S., and N. Sakaguchi. 2005. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int. Rev. Immunol. 24: 211-226.
12. - subpopulations. J. Immunol. 165: 3105-3110.
13. + T cells with a regulatory phenotype and function. Eur. J. Immunol. 35: 2896-2908.
14. + Tregs. J. Clin. Invest. 115: 2904-2913.
15. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol. 32: 3267-3275.
16. + regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun. 2: 1.
17. + regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J. Immunother. 25: 207-217.
18. high regulatory T cells increases with age. Clin. Exp. Immunol. 140: 540-546.
19. high regulatory T cells are not impaired in patients with primary Sjogren's syndrome. J. Autoimmun. 24: 235-242.
20. hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 106: 2018-2025.
21. + T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J. Clin. Immunol. 24: 155-161.
22. Dejaco, C., C. Duftner, and M. Schirmer. 2006. Are regulatory T-cells linked with aging? Exp. Gerontol. 41: 339-345.
23. Cuadros, C., F. J. Lopez-Hernandez, A. L. Dominguez, M. McClelland, and J. Lustgarten. 2004. Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect. Immun. 72: 2810-2816.
24. d-restricted CTL epitope. Gene Ther. 7: 2036-2040.
25. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
26. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
27. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962.
28. + T cells in aged mice. J. Immunol. 176: 6586-6593.
29. + T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J. Immunol. 175: 246-253.
30. Sharma, S., A. L. Dominguez, and J. Lustgarten. 2006. Aging affects the antitumor potential of dendritic cell vaccination, but it can be overcome by costimulation with anti-OX40 or anti-4-1BB. Exp. Gerontol. 41: 78-84.
31. Maletto, B. A., A. S. Ropolo, M. V. Liscovsky, D. O. Alignani, M. Glocker, and M. C. Pistoresi-Palencia. 2005. CpG oligodeoxynucleotides function as an effective adjuvant in aged BALB/c mice. Clin. Immunol. 117: 251-261.
32. Alignani, D., B. Maletto, M. Liscovsky, A. Ropolo, G. Moron, and M. C. Pistoresi-Palencia. 2005. Orally administered OVA/CpG-ODN induces specific mucosal and systemic immune response in young and aged mice. J. Leukocyte Biol. 77: 898-905.
33. Klinman, D. M., D. Currie, I. Gursel, and D. Verthelyi. 2004. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol. Rev. 199: 201-216.
34. Sharma, S., C. P. Karakousis, H. Takita, K. Shin, and S. P. Brooks. 2004. Cytokines and chemokines are expressed at different levels in small and large murine colon-26 tumors following intratumoral injections of CpG ODN. Neoplasia 6: 523-528.
35. + cells from young and old mice. Immunology 94: 380-387.
36. + cells and cell subsets from young